论文部分内容阅读
目的:观察穿刺引流术中应用尿激酶治疗老年高血压脑出血的临床疗效。方法:该组病例均自2013年5月至2015年9月收治的75例高血压脑出血患者的临床资料,根据数字随机分配的原则,将患者分为治疗组38例与对照组37例,患者入院后,均给予常规治疗干预,对照组患者给予开颅血肿清除术治疗,治疗组患者给予穿刺引流术联合尿激酶治疗,对比观察两组患者临床疗效及并发症发生情况。结果:两组患者总有效率及并发症发生率比较,结果具有明显差异(P<0.05)。结论:高血压脑出血患者采用穿刺引流术联合尿激酶,其疗效显著,安全性高,可临床推广应用。
Objective: To observe the clinical efficacy of urokinase in the treatment of senile hypertensive intracerebral hemorrhage in puncture and drainage. Methods: The clinical data of 75 patients with hypertensive intracerebral hemorrhage who were treated in our hospital from May 2013 to September 2015 were divided into treatment group (38 cases) and control group (37 cases) according to the principle of random number distribution. Patients were admitted to the hospital, were given conventional treatment intervention, control group patients given craniotomy hematoma removal, the treatment group were given puncture and drainage combined with urokinase treatment, the two groups were observed and compared the clinical efficacy and complications. Results: There was a significant difference between the two groups in total effective rate and complication rate (P <0.05). Conclusion: Hypertensive intracerebral hemorrhage using puncture and drainage in combination with urokinase has obvious curative effect, high safety and can be popularized clinically.